MYO
Next earnings: Aug 10, 2026 · After close
Signal
Mixed11
Price
1
Move+2.49%Positive session
Volume
1
Volume1.4× avgNormal activity
Technical
1
RSIRSI 50Momentum negative
PRICE
Prev Close
0.89
Open
0.86
Day Range0.84 – 0.92
0.84
0.92
52W Range0.61 – 3.45
0.61
3.45
11% of range
VOLUME & SIZE
Avg Volume
374.4K
FUNDAMENTALS
P/E Ratio
-2.5x
Not profitable
EPS (TTM)
Div Yield
No dividend
Beta
0.93
Market-like
Performance
1D
+2.49%
5D
+8.32%
1M
+14.62%
3M
+13.06%
6M
+11.55%
YTD
+0.01%
1Y
-74.51%
Best: 1M (+14.62%)Worst: 1Y (-74.51%)
Quick Read
TrendInsufficient MA data
Momentum
BULLISH
revenue +7% YoY · 66% gross margin
Valuation
FAIR
P/E not available
Health
WEAK
CR 2.7 · FCF negative
Lean Bullish
Key MetricsTTM
Market Cap$35.17M
Revenue TTM$41.21M
Net Income TTM-$15.12M
Free Cash Flow-$17.34M
Gross Margin66.0%
Net Margin-36.7%
Operating Margin-34.1%
Return on Equity-114.9%
Return on Assets-41.1%
Debt / Equity2.11
Current Ratio2.73
EPS TTM$-0.36

Intelligence analysis not yet available for this stock. Full AI-powered analysis may be available on the intelligence page.

Health Radar
2 strong4 concern
37/100
Liquidity
2.73Strong
Leverage
2.11Concern
Coverage
-11.2xConcern
ROE
-114.9%Concern
ROIC
-50.2%Concern
Cash
$14MStrong
ANALYST COVERAGE8 analysts
BUY
+20.9%upside to target
Buy
788%
Hold
113%
7 Buy (88%)1 Hold (13%)0 Sell (-1%)
Full report →
Stock Health
Composite Score
4 of 5 signals bullish
8/10
Technicals
RSI RangeRSI 50 — Bearish momentum
Volume
Volume FlowAccumulation — institutional buying
Fundamentals
Last EarningsBeat estimates
Analyst ConsensusBuy
LiquidityCurrent Ratio 2.73 — healthy liquidity
Upcoming Events
EEarnings ReportMay 18, 2026
Tomorrow
DEx-Dividend DateAug 14, 2026
In 89 days
PDividend PaymentAug 20, 2026
In 95 days
Technicals
Technical SetupBULLISH
Technicals →

Trend

RallyDeath Cross · 50D trails 200D by 18.2%

+18.8% vs SMA 50 · -2.9% vs SMA 200

Momentum

RSI50.0
Neutral territory
MACD+0.02
Above zero — bullish momentum · compressing
Market Position
Price Levels
52W High
$3.45+279.1%
EMA 200
$1.14+24.8%
Current
$0.9101
EMA 50
$0.8063-11.4%
52W Low
$0.6050-33.5%
52-Week RangeNear 52-week low
$0.605011th %ile$3.45
Squeeze SetupVolume-based
Moderate Squeeze Setup

Accumulation pattern present — more buying days than selling over the past 20 sessions. Volume conditions support gradual price improvement.

20-Day Money Flow
Acc days:5
Dist days:3
Edge:+2 acc
Volume Context
Avg Vol (50D)362K
Recent Vol (5D)
510K+41%

Based on volume distribution analysis. Direct short interest data (short float %, days to cover) is not available in current data sources.

Earnings & Analysts

ANALYST ESTIMATES

Consensus of 4 analysts
Analyst revisions:EPS↓ Revised DownRevenue↓ Revised Down

Analyst consensus estimates · Actuals replace estimates as reported

YearRevenue Est.Rev GthEPS Est.EPS GthRangeAnalysts
FY2025
$40.0M
$39.1M$40.8M
-$0.34
±3%
Moderate3
FY2026(current)
$44.4M
$42.9M$45.9M
+11.1%-$0.30
±14%
Moderate4
FY2027
$50.2M
$45.3M$55.0M
+12.9%-$0.24
±25%
Moderate4
Range confidence:Tight (high)ModerateWide (low)
Earnings HistoryMYO
Last 8Q
+16.6%avg beat
Beat 5 of 8 quartersMissed 1 Estimates falling
+57%
Q3'24
-29%
Q4'24
+50%
Q1'25
Q2'25
Q3'25
+18%
Q4'25
+11%
Q1'26
+25%
Q2'26
Beat
Miss
Estimate
Deeper color = bigger beat/miss
* Negative EPS shown at reduced height
Insider Activity
SEC Filings →
5 Buys/1 SellNet Buying
Mitchell MicahChief Commerci…
$78K
May 14
SELL
Getz Heather CDir
$14K
Mar 16
BUY
Kirk Thomas FDir
$51K
Mar 13
BUY
Getz Heather CDir
$51K
Mar 12
BUY
Kirk Thomas FDir
$2K
Nov 21
BUY
Kirk Thomas FDir
$4K
Nov 20
BUY
Financials

INSTITUTIONAL OWNERSHIP

1
Rosalind Advisors, Inc.
3.8M
2
BlackRock, Inc.
1.7M
3
GEODE CAPITAL MANAGEMENT, LLC
859K
4
Jefferies Financial Group Inc.
704K
5
Clearstead Advisors, LLC
426K
6
STATE STREET CORP
383K
7
Nuveen, LLC
370K
8
AQR CAPITAL MANAGEMENT LLC
319K
News & Activity

MYO News

About

myomo's mission is to enable individuals to overcome their paralysis by providing innovative, myoelectric orthotics and support services. we are committed to working with healthcare professionals to deliver high quality outcomes and patient satisfaction through research collaborations and continuing education programs. the company empowers persons with a neuromuscular disability to perform functional activities at home, at work, and in the community, resulting in an improved quality of life and lower healthcare costs.

Industry
Surgical and Medical Instrument Manufacturing
CEO
Paul Gudonis
Malcolm G. BockVice President of Engineering & Product Strategy
Paul R. GudonisPresident, Chief Executive Officer & Chairman
PeersHealth Care(7 companies)
Screen sector →
SymbolPriceDay %Mkt CapP/ERev GrwMarginELO
MYO
$0.91+2.49%$35M+2573.4%-3805.2%1500
$66.13-5.07%$13.0B+12626.1%-14525.8%1500
$94.92-3.79%$12.6B+3288.2%-4239.0%1500
$523.69-3.00%$12.1B+43205.3%-3008.0%1500
$227.72-1.96%$11.7B+6554.5%-2868.8%1500
$57.90-0.86%$11.2B50.3+1459.3%147.7%1500
$76.67-3.79%$10.8B+2325815.3%-19.7%1500
Sector avg-2.28%50.3+342217.4%-4045.5%1500